[Biological response modifiers and urological cancer]

Nihon Hinyokika Gakkai Zasshi. 1992 Jun;83(6):850-6.
[Article in Japanese]
No abstract available

MeSH terms

  • Carcinoma, Renal Cell / therapy
  • Combined Modality Therapy
  • Humans
  • Immunologic Factors / therapeutic use*
  • Immunotherapy, Adoptive
  • Kidney Neoplasms / therapy
  • Killer Cells, Lymphokine-Activated / transplantation
  • Urinary Bladder Neoplasms / therapy
  • Urologic Neoplasms / therapy*

Substances

  • Immunologic Factors